The mitral gap at 11 + 0 to 13 + 6 weeks: Marker of trisomy 21 or artifact?

Ultrasound in Obstetrics and Gynecology

Volumn 30, Issue 6, 2007, Pages 813-818

  Maiz, N ^a   Dagklis, T ^a   Huggon, I ^a   Allan, L ^a   Nicolaides, K H ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Doppler ultrasound; Fetal echocardiography; First trimester screening; Mitral gap, trisomy 21

Indexed keywords

ARTICLE; CHROMOSOME ABERRATION; DOPPLER ECHOGRAPHY; FETUS ECHOGRAPHY; HUMAN; MITRAL VALVE; NUCHAL TRANSLUCENCY MEASUREMENT; PRIORITY JOURNAL; TRISOMY;

DOWN SYNDROME; FEMALE; GENETIC MARKERS; HUMANS; INFANT, NEWBORN; MALE; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PROSPECTIVE STUDIES; RISK ASSESSMENT; TRICUSPID VALVE; TRICUSPID VALVE INSUFFICIENCY; ULTRASONOGRAPHY, PRENATAL;

EID: 36749102093     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.5170     Document Type: Article

References (12)

1. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998; 352: 343-346.
2. Hyett J, Perdu M, Sharland G, Snijders R, Nicolaides KH. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study. BMJ 1999; 318: 81-85.
3. Huggon IC, Ghi T, Cook AC, Zosmer N, Allan LD, Nicolaides KH. Fetal cardiac abnormalities identified prior to 14 weeks' gestation. Ultrasound Obstet Gynecol 2002; 20: 22-29.
4. Souka AP, Von Kaisenberg CS, Hyett JA, Sonek JD, Nicolaides KH. Increased nuchal translucency with normal karyotype. Am J Obstet Gynecol 2005; 192: 1005-1021.
5. Huggon IC, DeFigueiredo DB, Allan LD. Tricuspid regurgitation in the diagnosis of chromosomal anomalies in the fetus at 11-14 weeks of gestation. Heart 2003; 89: 1071-1073.
6. Faiola S, Tsoi E, Huggon IC, Allan LD, Nicolaides KH. Likelihood ratio for trisomy 21 in fetuses with tricuspid regurgitation at the 11 to 13+6-week scan. Ultrasound Obstet Gynecol 2005; 26: 22-27.
7. Falcon O, Faiola S, Huggon I, Allan L, Nicolaides KH. Fetal tricuspid regurgitation at the 11+0 to 13+6 week scan: association with chromosomal defects and reproducibility of the method. Ultrasound Obstet Gynecol 2006; 27: 609-612.
8. Borrell A, Antolin E, Costa D, Farre MT, Martinez JM, Fortuna A. Abnormal ductus venosus blood flow in trisomy 21 fetuses during early pregnancy. Am J Obstet Gynecol 1998; 179: 1612-1617.
9. Matias A, Gomes C, Flack N, Montenegro N, Nicolaides KH. Screening for chromosomal abnormalities at 10-14 weeks: the role of ductus venosus blood flow. Ultrasound Obstet Gynecol 1998; 6: 380-384.
10. Zoppi MA, Ibba RM, Floris M, Manca F, Axiana C, Monni G. Intracardiac Doppler assessment of left valve inflow in first-trimester fetuses with increased nuchal translucency: preliminary observations in trisomy 21. Ultrasound Obstet Gynecol 2006; 28: 77-81.
11. Huggon IC, Turan O, Allan LD. Doppler assessment of cardiac function at 11-14 weeks' gestation in fetuses with normal and increased nuchal translucency. Ultrasound Obstet Gynecol 2004; 24: 390-398.
12. Haak MC, Twisk JW, Bartelings MM, Gittenberger-de Groot AC, van Vugt JM. First-trimester fetuses with increased nuchal translucency do not show altered intracardiac flow velocities. Ultrasound Obstet Gynecol 2005; 25: 246-252.